Loading…

Antigenicity studies of prulifloxacin (NM441)

Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and w...

Full description

Saved in:
Bibliographic Details
Published in:Journal of toxicological sciences 1996-06, Vol.21, p.231-239
Main Authors: TATEDA, C, SAKAI, K, YAMAKAWA, S, NAKASUJI, T, NAKAMURA, T, SUMI, N, SHINDO, Y
Format: Article
Language:Japanese
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 239
container_issue
container_start_page 231
container_title Journal of toxicological sciences
container_volume 21
creator TATEDA, C
SAKAI, K
YAMAKAWA, S
NAKASUJI, T
NAKAMURA, T
SUMI, N
SHINDO, Y
description Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.
doi_str_mv 10.2131/jts.21.supplementi_231
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78177819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78177819</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-6334613da21fae0f84fd9c13ec36d760914bb27e7365776da24db4051b9b286b3</originalsourceid><addsrcrecordid>eNo9j81LxDAQxYMo67Lun6D0IKKHrplOmqTHZfELVr3ouSRpIpH0w6aF3f_egsXDMAPvN-_xCLkCuskA4f57iNOxiWPXBVvbZvBlhnBCliAlTbGQxSlZUpQyBczpOVnH6DWlCAIokwuykIIWwNmSpNvp-cs23vjhmMRhrLyNSeuSrh-Dd6E9KOOb5PbtlTG4uyBnToVo1_Nekc_Hh4_dc7p_f3rZbfdpBzkdUo7IOGClMnDKUieZqwoDaA3ySvApmmmdCSuQ50LwiWOVZjQHXehMco0rcvPn2_Xtz2jjUNY-GhuCamw7xlJIENMUE3g5g6OubVV2va9VfyznfpN-PesqGhVcrxrj4z-GIJExxF-78GF3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78177819</pqid></control><display><type>article</type><title>Antigenicity studies of prulifloxacin (NM441)</title><source>Free Full-Text Journals in Chemistry</source><creator>TATEDA, C ; SAKAI, K ; YAMAKAWA, S ; NAKASUJI, T ; NAKAMURA, T ; SUMI, N ; SHINDO, Y</creator><creatorcontrib>TATEDA, C ; SAKAI, K ; YAMAKAWA, S ; NAKASUJI, T ; NAKAMURA, T ; SUMI, N ; SHINDO, Y</creatorcontrib><description>Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.</description><identifier>ISSN: 0388-1350</identifier><identifier>EISSN: 1880-3989</identifier><identifier>DOI: 10.2131/jts.21.supplementi_231</identifier><identifier>PMID: 8709164</identifier><identifier>CODEN: JTSCDR</identifier><language>jpn</language><publisher>Tokyo: Japanese Society of Toxicology</publisher><subject>Anaphylaxis - immunology ; Animals ; Anti-Infective Agents - immunology ; Antigens - immunology ; Dioxolanes - immunology ; Female ; Fluoroquinolones ; Freund's Adjuvant - immunology ; Guinea Pigs ; Male ; Mice ; Mice, Inbred C57BL ; Passive Cutaneous Anaphylaxis - immunology ; Piperazines - immunology ; Quinolones - immunology ; Rats ; Serum Albumin - immunology ; Serum Albumin, Bovine - immunology</subject><ispartof>Journal of toxicological sciences, 1996-06, Vol.21, p.231-239</ispartof><rights>1996 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3183443$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8709164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TATEDA, C</creatorcontrib><creatorcontrib>SAKAI, K</creatorcontrib><creatorcontrib>YAMAKAWA, S</creatorcontrib><creatorcontrib>NAKASUJI, T</creatorcontrib><creatorcontrib>NAKAMURA, T</creatorcontrib><creatorcontrib>SUMI, N</creatorcontrib><creatorcontrib>SHINDO, Y</creatorcontrib><title>Antigenicity studies of prulifloxacin (NM441)</title><title>Journal of toxicological sciences</title><addtitle>J Toxicol Sci</addtitle><description>Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.</description><subject>Anaphylaxis - immunology</subject><subject>Animals</subject><subject>Anti-Infective Agents - immunology</subject><subject>Antigens - immunology</subject><subject>Dioxolanes - immunology</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Freund's Adjuvant - immunology</subject><subject>Guinea Pigs</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Passive Cutaneous Anaphylaxis - immunology</subject><subject>Piperazines - immunology</subject><subject>Quinolones - immunology</subject><subject>Rats</subject><subject>Serum Albumin - immunology</subject><subject>Serum Albumin, Bovine - immunology</subject><issn>0388-1350</issn><issn>1880-3989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNo9j81LxDAQxYMo67Lun6D0IKKHrplOmqTHZfELVr3ouSRpIpH0w6aF3f_egsXDMAPvN-_xCLkCuskA4f57iNOxiWPXBVvbZvBlhnBCliAlTbGQxSlZUpQyBczpOVnH6DWlCAIokwuykIIWwNmSpNvp-cs23vjhmMRhrLyNSeuSrh-Dd6E9KOOb5PbtlTG4uyBnToVo1_Nekc_Hh4_dc7p_f3rZbfdpBzkdUo7IOGClMnDKUieZqwoDaA3ySvApmmmdCSuQ50LwiWOVZjQHXehMco0rcvPn2_Xtz2jjUNY-GhuCamw7xlJIENMUE3g5g6OubVV2va9VfyznfpN-PesqGhVcrxrj4z-GIJExxF-78GF3</recordid><startdate>199606</startdate><enddate>199606</enddate><creator>TATEDA, C</creator><creator>SAKAI, K</creator><creator>YAMAKAWA, S</creator><creator>NAKASUJI, T</creator><creator>NAKAMURA, T</creator><creator>SUMI, N</creator><creator>SHINDO, Y</creator><general>Japanese Society of Toxicology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199606</creationdate><title>Antigenicity studies of prulifloxacin (NM441)</title><author>TATEDA, C ; SAKAI, K ; YAMAKAWA, S ; NAKASUJI, T ; NAKAMURA, T ; SUMI, N ; SHINDO, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-6334613da21fae0f84fd9c13ec36d760914bb27e7365776da24db4051b9b286b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1996</creationdate><topic>Anaphylaxis - immunology</topic><topic>Animals</topic><topic>Anti-Infective Agents - immunology</topic><topic>Antigens - immunology</topic><topic>Dioxolanes - immunology</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Freund's Adjuvant - immunology</topic><topic>Guinea Pigs</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Passive Cutaneous Anaphylaxis - immunology</topic><topic>Piperazines - immunology</topic><topic>Quinolones - immunology</topic><topic>Rats</topic><topic>Serum Albumin - immunology</topic><topic>Serum Albumin, Bovine - immunology</topic><toplevel>online_resources</toplevel><creatorcontrib>TATEDA, C</creatorcontrib><creatorcontrib>SAKAI, K</creatorcontrib><creatorcontrib>YAMAKAWA, S</creatorcontrib><creatorcontrib>NAKASUJI, T</creatorcontrib><creatorcontrib>NAKAMURA, T</creatorcontrib><creatorcontrib>SUMI, N</creatorcontrib><creatorcontrib>SHINDO, Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of toxicological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TATEDA, C</au><au>SAKAI, K</au><au>YAMAKAWA, S</au><au>NAKASUJI, T</au><au>NAKAMURA, T</au><au>SUMI, N</au><au>SHINDO, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigenicity studies of prulifloxacin (NM441)</atitle><jtitle>Journal of toxicological sciences</jtitle><addtitle>J Toxicol Sci</addtitle><date>1996-06</date><risdate>1996</risdate><volume>21</volume><spage>231</spage><epage>239</epage><pages>231-239</pages><issn>0388-1350</issn><eissn>1880-3989</eissn><coden>JTSCDR</coden><abstract>Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.</abstract><cop>Tokyo</cop><pub>Japanese Society of Toxicology</pub><pmid>8709164</pmid><doi>10.2131/jts.21.supplementi_231</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0388-1350
ispartof Journal of toxicological sciences, 1996-06, Vol.21, p.231-239
issn 0388-1350
1880-3989
language jpn
recordid cdi_proquest_miscellaneous_78177819
source Free Full-Text Journals in Chemistry
subjects Anaphylaxis - immunology
Animals
Anti-Infective Agents - immunology
Antigens - immunology
Dioxolanes - immunology
Female
Fluoroquinolones
Freund's Adjuvant - immunology
Guinea Pigs
Male
Mice
Mice, Inbred C57BL
Passive Cutaneous Anaphylaxis - immunology
Piperazines - immunology
Quinolones - immunology
Rats
Serum Albumin - immunology
Serum Albumin, Bovine - immunology
title Antigenicity studies of prulifloxacin (NM441)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T04%3A49%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigenicity%20studies%20of%20prulifloxacin%20(NM441)&rft.jtitle=Journal%20of%20toxicological%20sciences&rft.au=TATEDA,%20C&rft.date=1996-06&rft.volume=21&rft.spage=231&rft.epage=239&rft.pages=231-239&rft.issn=0388-1350&rft.eissn=1880-3989&rft.coden=JTSCDR&rft_id=info:doi/10.2131/jts.21.supplementi_231&rft_dat=%3Cproquest_pubme%3E78177819%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p150t-6334613da21fae0f84fd9c13ec36d760914bb27e7365776da24db4051b9b286b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78177819&rft_id=info:pmid/8709164&rfr_iscdi=true